Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | KRSA | ZD |
|---|---|---|
| Price | $30.72 | $55.98 |
| Change today | ▲ 0.75% | ▲ 1.41% |
| Market cap | $1.92B | $1.92B |
| Return, 3 months | +26.1% | +5.1% |
| Return, year to date | +245.6% | +59.3% |
| Return, 1 year | +83.6% | +41.6% |
| P/E (TTM) | -43.9 | 3.2 |
| P/B | 4.3 | 0.9 |
| P/E percentile vs own 5y | – | 2nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +72.5% | +13.7% |
| Analyst buy share | 100% | 50% |
| RSI (14) | 50 | 49 |
| 30-day volatility | 158.2% | 24.7% |
| Max drawdown, 1 year | -66.8% | -33.8% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
